Company Profile

ProterixBio Inc (AKA: BioScale Inc)
Profile last edited on: 11/16/2023      CAGE: 3C6J8      UEI: PLYYWFK1BP63

Business Identifier: Management of chronic diseases
Year Founded
First Award
Latest Award
Program Status
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

One Fortune Drive
Billerica, MA 01821
   (978) 901-6700
Location: Single
Congr. District: 06
County: Middlesex

Public Profile

Renamed ProterixBio in April 2016 (fdba BioScale), the firm is focused on addressing the unmet need for tools to provide a real-time, biological assessment of a patient's disease stated. Organized around development of proprietary blood-based biomarker tests to manage chronic respiratory diseases, the objctive is to have ProterixBio's products enable health care providers better to manage the condition of their patients, avoid ingunnecessary hospitalizations and improving outcomes at reduced health-care costs.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
Revenue Range
VC funded?
Privately Held
Stock Info
IP Holdings

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2008 2 NIH $1,502,505
Project Title: Novel Viral Load Diagnostic for Resource-Limited Setting
2006 2 Navy $824,123
Project Title: Advanced Oil Viscosity Measurement Technique
2005 2 CBD $840,777
Project Title: Monitoring Food and Water for Pathogens
2005 2 NIH $996,153
Project Title: Pathogen Biosensor Array for Syndrome-Based Diagnostics
2004 2 Army $833,475
Project Title: Proteomic Biomarker Diagnostics for Early Detection of Cancer using MEMS Biosensor Arrays

Key People / Management

  Andrew Abrams -- Chief Executive Officer

  Jaime E Arenas

  Paul Billings -- Experienced Biotech Executive And Genomics Expert

  Grace E Colon -- Executive Chairman

  Mike Contarino -- Executive VP of Operations

  Edward Crawley -- Co-Founder

  Paul J Durda

  Julio E Herrera -- Vp Operations & Assay Development

  Martin Latterich

  Mark Lundstrom -- co-Founder

  Brett P Masters -- Chief Technology Officer

  Michael Miller -- Vice President, Product Development

  Charles L Popkin -- Chief Financial Officer

  Alexis F Sauer-Budge

  Alok Srivastava